Publication
Use of Rituximab in Pemphigus Vulgaris/Foliaceus Patients During COVID-19 Pandemic
| dc.contributor.author | Aparício Martins, I | |
| dc.contributor.author | Cabete, J | |
| dc.date.accessioned | 2023-03-08T15:44:10Z | |
| dc.date.available | 2023-03-08T15:44:10Z | |
| dc.date.issued | 2022 | |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Port J Dermatol and Venereol. 2022;80(4):330-331 | pt_PT |
| dc.identifier.doi | 10.24875/PJDV.22000012 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/4443 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Sociedade Portuguesa de Dermatologia e Venereologia | pt_PT |
| dc.subject | HSAC DER | pt_PT |
| dc.subject | Pandemics | pt_PT |
| dc.subject | COVID-19 | pt_PT |
| dc.subject | Rituximab | pt_PT |
| dc.title | Use of Rituximab in Pemphigus Vulgaris/Foliaceus Patients During COVID-19 Pandemic | pt_PT |
| dc.title.alternative | Utilização de Rituximab em Doentes com Pênfigo Vulgar/Foliáceo Durante a Pandemia COVID-19 | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 331 | pt_PT |
| oaire.citation.startPage | 330 | pt_PT |
| oaire.citation.title | Portuguese Journal of Dermatology and Venereology | pt_PT |
| oaire.citation.volume | 80 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |